These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 13991599)

  • 1. Studies of hepatic excretory function. The effect of 17alpha-ethyl-19-nortestosterone on sulfobromophthalein sodium (BSP) metabolism in man.
    SCHERB J; KIRSCHNER M; ARIAS I
    J Clin Invest; 1963 Mar; 42(3):404-8. PubMed ID: 13991599
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. I. IN NORMAL SUBJECTS AND PATIENTS WITH HEPATIC DISEASE.
    SCHOENFIELD LJ; FOULK WT; BUTT HR
    J Clin Invest; 1964 Jul; 43(7):1409-18. PubMed ID: 14192521
    [No Abstract]   [Full Text] [Related]  

  • 3. A new look at the plasma disappearance of sulfobromophthalein (BSP): correlation with the BSP transport maximum and the hepatic plasma flow in man.
    Häcki W; Bircher J; Preisig R
    J Lab Clin Med; 1976 Dec; 88(6):1019-31. PubMed ID: 993641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [EFFECT OF SOME 17-ALPHA-ALKYLATED STEROIDS ON THE BSP METABOLISM IN MAN].
    ELEWAUT A; BARBIER F; VERSIECK J
    Tijdschr Gastroenterol; 1964; 7():36-51. PubMed ID: 14272141
    [No Abstract]   [Full Text] [Related]  

  • 5. A practical approach to quantitate hepatic excretory function.
    Bircher J; Häcki W
    Yale J Biol Med; 1974 Sep; 47(3):196-201. PubMed ID: 4446630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. 3. DEMONSTRATION OF A TRANSPORT MAXIMUM (TM) FOR BILIARY EXCRETION OF BSP.
    SCHOENFIELD LJ; MCGILL DB; FOULK WT
    J Clin Invest; 1964 Jul; 43(7):1424-32. PubMed ID: 14192523
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. II. THE EFFECT OF ARTIFICIALLY INDUCED FEVER, NORETHANDROLONE (NILEVAR), AND IOPANOIC ACID (TELAPAQUE).
    SCHOENFIELD LJ; FOULK WT
    J Clin Invest; 1964 Jul; 43(7):1419-23. PubMed ID: 14192522
    [No Abstract]   [Full Text] [Related]  

  • 8. Biliary transport and hepatic storage of sulfobromophthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease.
    WHEELER HO; MELTZER JI; BRADLEY SE
    J Clin Invest; 1960 Jul; 39(7):1131-44. PubMed ID: 13844286
    [No Abstract]   [Full Text] [Related]  

  • 9. The biliary dynamics of the metabolites of sulfobromophthalein sodium (BSP) in man.
    MONROE LS; KITTINGER AL
    J Lab Clin Med; 1961 Sep; 58():468-76. PubMed ID: 13772068
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatic activity of glutathione transferase and bromsulphalein metabolism].
    Serra MA; Caballero A; Aparisi L; Rodrigo JM; Del Olmo JA; Ferrando J; Wassel AH; Reig G; Bixquert M
    Rev Esp Enferm Dig; 1991 Feb; 79(2):112-6. PubMed ID: 2059513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of hepatic excretory function. 3. Effect of hypopituitarism on the hepatic excretion of sulfobromophthalein sodium in man.
    Schmidt ML; Gartner LM; Arias IM
    Gastroenterology; 1967 Jun; 52(6):998-1002. PubMed ID: 6026493
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of BSP, especially the result of BSP metabolism, in the diagnosis of liver diseases].
    Ito K; Nakagawa J
    Rinsho Byori; 1969 Feb; 17(2):103-8. PubMed ID: 5814329
    [No Abstract]   [Full Text] [Related]  

  • 13. EFFECT OF ETHYL ALCOHOL ON HEPATIC CIRCULATION, SULFOBROMOPHTHALEIN CLEARANCE, AND HEPATIC GLUTAMIC-OXALACETIC TRANSAMINASE PRODUCTION IN MAN.
    CHILDS AW; KIVEL RM; LIEBERMAN A
    Gastroenterology; 1963 Aug; 45():176-81. PubMed ID: 14051728
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interpretation of bromsulphalein (BSP) value in liver diseases--with special reference to the analytical result of BSP metabolism].
    Ito K; Nakagawa J; Nakano H; Tamai Y; Maeda K
    Nihon Rinsho; 1967 Aug; 25(8):1917-25. PubMed ID: 5627398
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical value of the fractional clearance of BSP in hepatic functional exploration and in diagnosis of chronic liver diseases].
    Oancea R; Suman S; Filip V; Macarie O; Ciocan A
    Med Interna (Bucur); 1966 Oct; 18(10):1233-40. PubMed ID: 5978450
    [No Abstract]   [Full Text] [Related]  

  • 16. Narcotic effects on hepatic disposition of sulfobromophthalein in rats.
    Hurwitz A; Fischer HR
    J Pharmacol Exp Ther; 1983 Oct; 227(1):68-72. PubMed ID: 6620173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [THE VALUE OF FRACTIONAL CLEARANCE OF BSP IN THE DIAGNOSIS OF CHRONIC HEPATOPATHIES].
    NICOLAESCU T; FELBERG B; RUSOVICI L
    Med Interna (Bucur); 1964 Aug; 16():959-67. PubMed ID: 14192603
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug hazards-sulfobromophthalein sodium(BSP).
    Godwin JT
    South Med J; 1968 Jul; 61(7):696,702. PubMed ID: 5664517
    [No Abstract]   [Full Text] [Related]  

  • 19. [BSP--its values in various liver diseases and the function test by 121-I-BSP].
    Ito K; Nakagawa J; Minakuchi C; Tamai Y; Nakano H
    Nihon Rinsho; 1971 Jan; 29():Suppl:341-50. PubMed ID: 4928278
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of sodium taurocholate on the hepatic metabolism of sulfobromophthalein sodium (BSP). The role of bile flow.
    Boyer JL; Scheig RL; Klatskin G
    J Clin Invest; 1970 Feb; 49(2):206-15. PubMed ID: 5411780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.